Piramal Pharma Acquires Yapan Bio
Piramal Pharma strengthens its biologics CDMO business, converting Yapan Bio from associate company to subsidiary and expanding vaccine and biologics manufacturing capabilities.
Pharma
Cancer Vaccines Get Their First Real Win
The first personalized mRNA cancer therapy to beat the standard of care is now headed for regulators.
Modular Automation Moves from Vision to GMP Reality
A pharma project demonstrates how MTP can accelerate integration while reducing validation effort.
Eurofins CDMO Alphora Expands Capacity and HPAPI Capabilities
Eurofins CDMO Alphora has expanded its kilolab and high-potency active pharmaceutical ingredient (HPAPI) development and manufacturing capabilities in Ontario.
Novo Nordisk Partners with Amazon to Boost Drug Discovery
Novo Nordisk and Amazon Web Services (AWS) have partnered to accelerate drug discovery with AI. A co-innovation hub in London will facilitate efforts to reduce the time to market for future medicines.
Beacons of the Start-up Scene, Part 9: Biovox
Biovox develops bioplastic compounds that offer features such as inherent antimicrobial properties. At the same time, they are environmentally friendly.
Cambrex Milan Constructs New $30 Million R&D Facility; Celebrates 80th Anniversary
CDMO Cambrex started construction on a new R&D facility at its Milan, Italy site. The $30 million investment adds advanced analytical development and process R&D capabilities.
Bristol Myers Squibb Invests $2.3 Billion in Houston Campus
The investment furthers the company's $40 billion commitment to invest in American innovation and manufacturing.
Mabion and KriSan Biotech Launch Partnership for Next-Gen ADCs
The partners will combine their unique capabilities to jointly develop, offer, and deliver integrated services in the Antibody-Drug Conjugates (ADC) segment for the global pharmaceutical and biotechnology industries.
Lonza and Engitix Announce License Agreement to Advance Targeted ADC Development
Agreement advances new therapies through Engitix’s unique focus on the extracellular matrix (ECM).
Brenntag Pharma Enters into a Strategic Partnership with Evonik
An exclusive distribution agreement for Evonik Rexim amino acids strengthens Brenntag's role in the biopharma and API markets.
Samsung Biologics to Acquire PolyPeptide in All-Cash Deal, Expanding Global Manufacturing
PolyPeptide's specialized peptide expertise and global multi-site network to strengthen Samsung Biologics' multi-modality and global manufacturing excellence.
How FDA's PreCheck Pilot Aims to Speed Up US Drug Manufacturing
DCAT reports that FDA has selected seven companies for its new PreCheck Pilot Program, designed to encourage US-based drug manufacturing through earlier engagement and a more predictable regulatory path.
Olon Expands Concord, Ohio Site, Doubling US Manufacturing Capacity
Olon has completed a major expansion at its Concord, Ohio facility, doubling production capacity and strengthening the site's role as a US manufacturing hub within its global development network.
Fujifilm Biotechnologies Selected for FDA PreCheck Pilot Program to Advance US Drug Manufacturing
Fujifilm Biotechnologies' Holly Springs, NC facility has been chosen as one of seven participants in the FDA's PreCheck Pilot Program, aimed at strengthening US pharmaceutical manufacturing and regulatory readiness.
Innexis Acquires Novartis's Kundl Site
Innexis plans to acquire the multi-user facility in Kundl, Tyrol, from Novartis.
Evonik Invests $100 Million in US API Production
Evonik is modernizing the API production at its Tippecanoe site in the US Over the next five years, the company will invest $100 million in upgrading key plant components.
Siddharth Mittal Appointed as Managing Director & CEO of Syngene International
Syngene International announced that Siddharth Mittal has assumed the role of Managing Director and Chief Executive Officer of the Company, effective 1 July 2026.
Symeres and Axxam Unite Drug Discovery Platforms Under Single Scientific Chief
Russell Thomas, who has held senior roles at both organisations, takes on the joint CSO position as Symeres and Axxam push to offer clients a single pipeline spanning target screening to IND-ready drug candidates.
Adragos and Towa to Produce 1.5 Billion Tablets a Year
CDMO Adragos Pharma Kawagoe and Towa Pharmaceutical have agreed to a manufacturing partnership that will nearly triple solid-dosage capacity, shoring up Japan's fragile generics supply chain.
Lonza Expands Visp Site to Meet Demand in ADCs
Lonza to expand payload-linker manufacturing capacity in Visp (CH) to support the rapidly growing antibody-drug conjugate (ADC) market.
IMCD Launches State-of-the-Art Pharma & Food Hub in New Jersey
IMCD has opened a new Pharmaceutical Technical Centre and Food & Nutrition Hub in Allendale, NJ — bringing labs, co-creation space, and global expertise together to speed up product development.
Digitalization as a Strategic Lever in R&D
Digital Innovation: a key driver of competitiveness and sustainability across the pharmaceutical industry.
Biopharma Innovation: From Bold Idea to Delivered Product
Biopharma has never lacked ambition. The gap has always been between scientific promise and a product on a shelf. That's exactly where the most consequential innovation is happening now.
Trusted Evidence in the Age of AI
AI in pharma has moved past the hype cycle and into implementation. The organizations that pull ahead won't have the most sophisticated models — they'll have the strongest evidence foundation underneath them.
Digital Twins for the Pharma Supply Chain
The key to effective demand & supply planning in the pharmaceutical industry
Elevating AI-Driven Discovery: Simplifying Complexity with CDD Vault
Drug discovery generates enormous amounts of data, but turning it into meaningful insight is a major challenge.
Pharma 4.0: Big Promises, Poor Data - What’s Going Wrong?
Pharma 4.0 is high on every strategic agenda. Yet many struggle to turn digital ambitions into measurable results. Projects stall, systems don’t align, and valuable insights remain locked in fragmented data structures.
Closing the Gap Between Lab and Production
Shorter development cycles and complex active ingredients are demanding integrated solutions. Guided by the principle "Together – from lab to production," Fette Compacting positions its R&D Solutions as a partnership.
From Catalogue to Collaboration: Enamine’s 35 Years of Advancing Drug Discovery
Marking 35 years of innovation, this collection celebrates how Enamine has grown from a regional supplier into a trusted global partner.
Lonza Issues License to Antharis Therapeutics for ADCs
Lonza and Antharis Therapeutics announced an exclusive, target-specific licensing agreement to develop novel dual-payload ADCs targeting gastrointestinal (GI) cancers.
Recipharm Expands US Sterile Fill and Finish Capabilities
Recipharm announced a multi-million-dollar investment in its US operations, strengthening its ability to support pharma and biotech companies with advanced sterile fill and finish services.
Chiesi Group Acquires KalVista Pharmaceuticals for $1.9 Billion
Chiesi Group has completed its acquisition of KalVista Pharmaceuticals, marking the Italian biopharmaceutical group's largest deal to date.
Siegfried Inaugurates Pharma API plant in Minden
Siegfried has inaugurated a new large-scale API production facility at its German site in Minden.
Sponsored • News
Predictive Simulation in Pharma Production
Simulation Unlocks Capacity, Boosts Reliability, Drives Smarter Decisions
Groupe Novasep
Agilent Technologies Inc.
Novartis International AG
Miebach Consulting GmbH
AmbioPharm, Inc.
Arthur D. Little
Datamonitor Group
CHEManager International c/o Wiley-VCH GmbH
GlaxoSmithKline (GSK) plc
UBM Live
RX Trace
GETEC Group
Accenture
Managm. Consult. Chemicals
Piramal Pharma
Abzena
Roquette
SchüllerConsulting
Evonik Industries AG
Enamine Ltd.
Sanofi S.A.
EvaluatePharma
Cambrex Corporation
Porsche Consulting
Wiley-VCH
CDD - Collaborative Drug Discovery
Godrej Astec LifeSciences Limited (Astec Life)
Curia
ACG
Scienceindustries - Wirtschaftsverband Chemie Pharma Life Sciences
Recipharm
Blue Sphere Health Ltd.
EMG The European Marketing Group BV
Catalent Inc.
Roche Group
PA Consulting Group
Ontario Int. Marketing Ct.
KPMG AG Wirtschaftsprüfungsges.
Pfizer, Inc.
Olon S.p.A.
Hovione
Avantor
Thomson Reuters
Brenntag SE
Fujifilm
Datamonitor Group
WeylChem International GmbH
Forma Life Sciences
CordenPharma International
SCIEX